Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Mineralys First Quarter 2025 Earnings Conference Call. At this time, all lines are in listen-only mode.
Mineralys Therapeutics Inc. (MLYS)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.50 | 259,259 | $3,499,996.50 | 8,903,838 | 2025-03-13 | Filing | |
| $13.50 | 600,000 | $8,100,000.00 | 5,674,916 | 2025-03-13 | Filing | |
| $13.50 | 600,000 | $8,100,000.00 | 5,674,916 | 2025-03-13 | Filing | |
| $13.50 | 1,296,296 | $17,499,996.00 | 4,280,051 | 2025-03-13 | Filing | |
| $13.50 | 555,555 | $7,499,992.50 | 5,074,916 | 2024-02-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.60 | 11,366 | $165,931.10 | 101,651 | 2025-06-13 | Filing | |
| $15.29 | 11,366 | $173,773.64 | 106,669 | 2025-05-14 | Filing | |
| $14.83 | 8,400 | $124,572.00 | 111,686 | 2025-04-14 | Filing | |
| $13.69 | 2,966 | $40,613.14 | 120,086 | 2025-04-14 | Filing | |
| $12.06 | 10,757 | $129,684.24 | 215,340 | 2025-04-11 | Filing |
News See All
10 Pump and Dump Stocks Favored by Hedge Funds
Pump and dump stocks are typically characterized by high 52-week volatility, often experiencing rapid price surges followed by sharp declines.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Mineralys Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all lines are in a listen-only mode.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Mineralys Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2024 Earnings Call Transcript
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2024 Earnings Call Transcript August 13, 2024Mineralys Therapeutics, Inc. misses on earnings expectations.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Mineralys First Quarter 2024 Earnings Conference Call. At this time all lines are in listen-only mode.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.85.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Mineralys Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions].
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Mineralys Second Quarter 2023 Earnings Call [Operator Instructions]. As a reminder, this conference is being recorded.
Billionaire Hedge Funds
